These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7080769)

  • 1. [Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children].
    Vasil'eva RI; Osidak LV; Bichurina MA; Mukhina LP; Chudina LV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Apr; (4):96-8. PubMed ID: 7080769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a study of new preparations of inactivated whole-virion influenza vaccines for the protection of children in the USSR].
    Vasil'eva RI; Lonskaia NI; Nefedova LA; Iaroshevskaia IIu; Bichurina MA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):38-42. PubMed ID: 3591124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the effectiveness of inactivated influenza vaccine preparations].
    Ismagulov AT; Nurgaliev KN
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):84-7. PubMed ID: 6880484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The results of state trials of inactivated influenza vaccines for children].
    Vasil'eva RI; Smirnova LA; Rudenko LG; Drinevskiĭ VP; Tsaritsina IM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):49-54. PubMed ID: 2968738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime].
    Vasil'eva RI; Liamtseva GA; Riazantseva TG; Oleĭnikova EV; Sosunov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):10-4. PubMed ID: 2939666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the potential use of inactivated influenza centrifuged vaccines with various hemagglutinin levels for immunizing schoolchildren].
    Slobodeniuk AV; Shadrin AS; Andrievskaia RA; Aleksandrova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):52-6. PubMed ID: 3434050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the reactogenicity and antigenic activity of Soviet inactivated influenza vaccines].
    Rudenko LG; Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):79-84. PubMed ID: 6464576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.
    Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
    Khan AS; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya NL; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger LB; Couch R; Kendal A; Cox N
    J Infect Dis; 1996 Feb; 173(2):453-6. PubMed ID: 8568310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old].
    Rudenko LG; Grigor'eva EP; Drinevskiĭ VP; Koval' TA; Doroshenko EM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):41-6. PubMed ID: 2970743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Potter CW; Clark A; Jennings R; Schild GC; Wood JM; McWilliams PK
    J Biol Stand; 1980; 8(1):35-48. PubMed ID: 6995458
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
    Gruber WC; Belshe RB; King JC; Treanor JJ; Piedra PA; Wright PF; Reed GW; Anderson E; Newman F
    J Infect Dis; 1996 Jun; 173(6):1313-9. PubMed ID: 8648202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inoculation properties of a pediatric variant of adsorbed influenza chemical vaccine].
    Berdnikova LF; Vasiaev AI; Pushkarev MA; Vlasov AR; D'iakonova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):48-52. PubMed ID: 3434049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response.
    Gruber WC; Darden PM; Still JG; Lohr J; Reed G; Wright PF
    Vaccine; 1997; 15(12-13):1379-84. PubMed ID: 9302748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.